Address
New Science Ventures
645 Madison Avenue
20th Floor
New York, NY 10022
United States
Email
Recent investment activity
KANDO id: 39519
Corporate information
Official name
New Science Ventures, LLC
Also known as
NSV
Registration country
Company type
Venture capital firm investing in both early and late stage companies using novel scientific approaches to address significant unmet needs.Overview
New Science Ventures, LLC (NSV) is a venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value. NSV invests in companies using science-based innovations to address market needs in the life sciences and information technology sectors.
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| New Science Ventures Fund III (Offshore) LP | Venture | |||
| New Science Ventures Fund III LP | Venture |
Funding rounds
Actual initial investment stage
Series A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 20 of 20| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
|
Paradigm Diagnostics Inc | Series B USD 3,000,000 (USD 3,000,000) | ||||
|
BrightVolt Inc | Design, development and scale manufacturing of ultra-thin film batteries. | Series B led the round USD 5,000,000 (USD 5,000,000) | |||
|
VUV Analytics Inc | Developer of vacuum ultraviolet absorption spectroscopy. | Series B led the round | |||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Seahorse Bioscience Inc | A developer of test and measurement equipment that is primarily used for cell assay tests in research laboratories. | Venture | |||
|
Vaultive Inc | Developer of cloud-based data encryption. | Series A Initial investment led the round | |||
|
|
Juventas Therapeutics Inc | Series B | ||||
|
|
Achronix Semiconductor Corp | Series C | ||||
|
|
Celleration Inc | Medical device company focused on developing and commercializing therapeutic ultrasound products | Series E | |||
|
|
Seahorse Bioscience Inc | A developer of test and measurement equipment that is primarily used for cell assay tests in research laboratories. | Series D | |||
|
|
Celleration Inc | Medical device company focused on developing and commercializing therapeutic ultrasound products | Series D | |||
|
|
Achronix Semiconductor Corp | Series B | ||||
|
|
TherOx Inc | Series E | ||||
|
|
Xoft Inc | Developer of electronic brachytherapy (eBx) systems for radiation oncology applications. | Series D | |||
|
|
Achronix Semiconductor Corp | Series A | ||||
|
|
Light Sciences Oncology Inc | Drug-device cancer therapy | Series A | |||
|
|
Celleration Inc | Medical device company focused on developing and commercializing therapeutic ultrasound products | Series C | |||
|
|
Biovex Inc (Biovex Group Inc) | Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. | Series E | |||
|
|
Biovex Inc (Biovex Group Inc) | Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. | Series F | |||
|
|
BioProcessors Corp | N/A | ||||
|
|
Trellis Bioscience | N/A |
Team
| Employee | Position | ||
|---|---|---|---|
| Thomas J A Lavin | |||
| Somu Subramaniam |